Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: Twelve-month results from the PATENT study

Journal of Endovascular Therapy

Volumn 21, Issue 1, 2014, Pages 52-60

  Schmidt, Andrej ^a   Zeller, Thomas ^b   Sievert, Horst ^c   Krankenberg, Hans ^d   Torsello, Giovanni ^e   Stark, Matthew A ^f   Scheinert, Dierk ^a  

^a Park Krankenhaus Leipzig   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c Cardiovascular Center   (Germany)

^d Schofer and Partner   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Spectranetics   (United States)

Author keywords

Atherectomy; Balloon angioplasty; Femoropopliteal segment; In stent restenosis; Laser; Patency; Popliteal artery; Restenosis; Stent; Superficial femoral artery; Target lesion revascularization

Indexed keywords

AGED; AMPUTATION; ANKLE BRACHIAL INDEX; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; LASER THERAPY; LASERS, EXCIMER; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; REOPERATION; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84894254527     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4538R.1     Document Type: Article

References (28)

1. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749. (Pubitemid 46842791)
2. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
3. Sabeti S, Mlekusch W, Amighi J, et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005;12:6-12. (Pubitemid 40229383)
4. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the resilient randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
5. Dick P, Sabeti S, Mlekusch W, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. 2008;248:297-302.
6. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoro-popliteal stenting. J Am Coll Cardiol. 2012;59:16-23.
7. Stabile E, Virga V, Salemme L, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60:1739-1742.
8. Rastan A, Sixt S, Schwarzwälder U, et al. Initial experience with directed laser atherectomy using the Clirpath Photoablation Atherectomy System and Bias sheath in superficial femoral artery lesions. J Endovasc Ther. 2007;14:365-373. (Pubitemid 47057921)
9. Dave RM, Patlola R, Kollmeyer K, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009;16:665-675.
10. Jaff M, Dake M, Pompa J, et al. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc Interv. 2007;70:460-462. (Pubitemid 350194998)
11. Armstrong EJ, Singh S, Singh GD, et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv. 2013;82:1168-1174.
12. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 1997;95:1998-2002. (Pubitemid 27184264)
13. Zeller T, Dake MD, Tepe G, et al. Treatment of femoropopliteal in-stent restenosis with pacli-taxel-eluting stents. JACC Cardiovasc Interv. 2013;6:274-281.
14. Laird JR, Yeo KK, Rocha-Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv. 2012;80:852-859.
15. Zeller T, Rastan A, Sixt S, et al. Long-term results after atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006;48:1573-1578. (Pubitemid 44528188)
16. Trentmann J, Charalambous N, Diawanscher M, et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino). 2010;51:551-560.
17. Shammas NW, Shammas GA, Hafez A, et al. Safety and one-year revascularization outcome of excimer laser ablation therapy in treating instent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:341-344.
18. Yeo KK, Malik U, Laird JR, et al. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv. 2011;78:604-608.
19. Shammas NW, Coiner D, Shammas GA, et al. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther. 2009;16:197-202.
20. Lam RC, Shah S, Faries PL, et al. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial artery. J Vasc Surg. 2007;46:1155-1159. (Pubitemid 350267070)
21. Karnabatidis D, Katsanos K, Kagadis GC, et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther. 2006:13:269-280. (Pubitemid 44775201)
22. Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv. 2006;67:417-422. (Pubitemid 43346746)
23. Shammas NW, Dippel EJ, Coiner D, et al. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther. 2008;15:270-276. (Pubitemid 351969140)
24. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
25. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. (Pubitemid 351240748)
26. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831-840.
27. Van Den Berg JC, Pedrotti M, Canevascini R, et al. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg (Torino). 2012;53:215-222.
28. Gandini R, Del Giudice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center prospective randomized study. J Endovasc Ther. 2013;20:805-814.